However, challenges identified decades ago remain relevant today, leading to the conclusion that, although IgM detection will likely continue to play an integral role in diagnostic panels, significant progress will ultimately depend on the exploration of alternative biomarkers of recent infection. This evidence concerns the gene CD40LG and infection.